Compare OGS & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGS | HAE |
|---|---|---|
| Founded | 1906 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 5.4B |
| IPO Year | 2013 | 1996 |
| Metric | OGS | HAE |
|---|---|---|
| Price | $79.55 | $119.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 11 |
| Target Price | $85.17 | ★ $124.50 |
| AVG Volume (30 Days) | 547.8K | ★ 688.1K |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 2.78 | 0.72 |
| Revenue | ★ $2,578,005,000.00 | $910,373,000.00 |
| Revenue This Year | $2.03 | $6.21 |
| Revenue Next Year | $3.75 | $5.54 |
| P/E Ratio | ★ $28.19 | $165.64 |
| Revenue Growth | ★ 42.54 | N/A |
| 52 Week Low | $70.37 | $49.96 |
| 52 Week High | $90.78 | $123.77 |
| Indicator | OGS | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 66.87 | 64.30 |
| Support Level | $78.38 | $115.49 |
| Resistance Level | $79.79 | $123.77 |
| Average True Range (ATR) | 1.31 | 2.98 |
| MACD | 0.48 | -0.36 |
| Stochastic Oscillator | 95.20 | 70.37 |
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. It operates in one reportable business segment: regulated public utilities that deliver natural gas to residential, commercial, and transportation customers.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.